Related Experiment Video
Updated: May 17, 2026
03:57
Transmesenteric Laparoscopic Pyeloplasty in Trendelenburg Position for Horseshoe Kidney with Hydronephrosis
Published on: July 8, 2025
A translational approach to congenital non-obstructive hydronephrosis
Robyn P Thom1, Norman D Rosenblum
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto Medical Discovery Towers, 101 College Street, Toronto, Ontario, Canada, M5G 1 L7.
Pediatric Nephrology (Berlin, Germany)
|October 12, 2012
Summary
Congenital hydronephrosis affects 1-2% of pregnancies. Novel therapies targeting GLI3 repressor formation may offer new treatment options for non-obstructive cases.
Area of Science:
- Pediatric Urology
- Developmental Biology
- Renal Pathophysiology
Background:
- Congenital hydronephrosis, a common prenatal finding, involves renal collecting system dilation.
- Most cases are non-obstructive and resolve or stabilize spontaneously.
- Surgical intervention is the current treatment for severe, persistent conditions.
Purpose of the Study:
- To review the pathobiology and clinical management of non-obstructive hydronephrosis.
- To explore the role of hedgehog signaling and GLI3 repressor in renal development.
- To propose novel therapeutic strategies targeting GLI3 repressor formation.
Main Methods:
- Literature review of congenital hydronephrosis pathobiology.
- Analysis of recent data on hedgehog signaling in renal development.
- Exploration of GLI3 repressor formation mechanisms.
Main Results:
- Hedgehog signaling is crucial for renal collecting system development.
- GLI3 repressor formation is a key regulatory step in this process.
- Inhibitors of GLI3 repressor formation show therapeutic potential.
Conclusions:
- Non-obstructive congenital hydronephrosis management requires further therapeutic innovation.
- Targeting GLI3 repressor formation presents a promising avenue for novel treatments.
- Understanding hedgehog signaling pathways can guide future therapeutic development.
